ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Paragon 28 Launches Comprehensive Supramalleolar Osteotomy System

Paragon 28, Inc. (NYSE: FNA) is pleased to announce the launch of its Gorilla® Supramalleolar Osteotomy (SMO) Plating and PRESERVE™ SMO Allograft System which were developed to provide surgeons versatility in plate selection and surgical approach for supramalleolar osteotomies. The system includes patent pending drilling and cutting guides to facilitate repeatable and controlled anterior dome, medial opening, and closing wedge osteotomies. The system also includes a patent pending allograft cutting jig designed to shape the PRESERVE™ SMO Allograft Wedge to match the intended correction while reducing time and technicality of the procedure. Six plates are included in the system for anterior or medial approaches and include multiple spanning distances to accommodate varying correction.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230523005148/en/

Gorilla® SMO Anterior Dome, Medial Closing Wedge, and Medial Opening Wedge Plating Configurations (Photo: Business Wire)

Gorilla® SMO Anterior Dome, Medial Closing Wedge, and Medial Opening Wedge Plating Configurations (Photo: Business Wire)

Mark Myerson, MD, Gorilla® SMO design surgeon, said, "Paragon28 has introduced an outstanding and precise supramalleolar osteotomy plating system. It is extremely accurate, enabling the surgeon to obtain optimal correction with cutting and drill guides and a truly unique and ingenious way to cut a PRESERVE™ Allograft Wedge for an opening wedge osteotomy."

Paragon 28’s CEO, Albert DaCosta, commented, “Hindfoot deformity correction and arthroplasty are two of the fastest growing segments in the foot and ankle market and the Gorilla® SMO Plating and Allograft System offers surgeons a streamlined and reproducible means to achieve deformity correction while preserving the ankle joint. We are very excited to have a comprehensive system which will allow surgeons to address tibial deformities and stage for total ankle arthroplasty supporting our growing APEX™ Total Ankle Arthroplasty System.”

The addition of the Gorilla® SMO Plating and Allograft System bolsters Paragon 28’s Precision Ankle Solutions product offering, which includes the Gorilla® Ankle Fracture Plating System, APEX 3D™ Total Ankle Replacement, Silverback™ Ankle Fusion Plating System, Phantom® TTC Nail System, and Phantom® ActivCore™ Nail System. With this comprehensive portfolio, Paragon 28® provides its customers with innovative ankle solutions for trauma, arthritis, and limb salvage.

Paragon 28® is grateful for the significant contributions that Woo Chun Lee, MD, Mark Myerson, MD, Cassandra Tomczak, DPM, and Federico Usuelli, MD made in the design of this system.

About Paragon 28, Inc.

Based in Englewood, CO., Paragon 28, is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives. From the onset, Paragon 28® has provided innovative orthopedic solutions, procedural approaches and instrumentation that cover a wide range of foot and ankle ailments including fracture fixation, forefoot, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, Charcot foot and orthobiologics. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent, and reproducible.

Contacts

Investor Contact:

Matt Brinckman

Senior Vice President, Strategy and Investor Relations

(720) 912-1332

mbrinckman@paragon28.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  233.22
+4.06 (1.77%)
AAPL  278.85
+1.30 (0.47%)
AMD  217.53
+3.29 (1.54%)
BAC  53.65
+0.66 (1.25%)
GOOG  320.12
-0.16 (-0.05%)
META  647.95
+14.34 (2.26%)
MSFT  492.01
+6.51 (1.34%)
NVDA  177.00
-3.26 (-1.81%)
ORCL  201.95
-3.01 (-1.47%)
TSLA  430.17
+3.59 (0.84%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.